Blog / Archives
Rayno Biopharmaceutical Portfolio Nov. 1, 2013 YTD Performance…Update 1
Updated 2/11/15 see chart below Rayno 2013 Picks Outperform Biotechnology Indices and Funds Biopharmaceutical stocks hit all time highs in 2013 with major ETFs up as follows YTD: FBT ($65) up 41%,...
Rayno Life Science Scoreboard- October 2013- Amidst Sell-Off
Equities: The Only Game in Town With Rates Under 3%? October, normally a month to be cautious on the market, proved that trends can be misleading even in the midst of turbulent times in Washington....
Risk Rising in Mid and Small Cap Biopharmaceutical Stocks Update 2p EDT
Profit Taking Continues With Speculative Biotech Stocks Many of you who trade biopharmaceutical stocks know that $1B may be considered a small cap stock. As we mentioned in yesterday's post there...
Biotechnology Bull Market Gets Second Wind To All Time Highs: ALR, GILD, ILMN,
Dow, S&P and Biotech Sector Hit All Time Highs NASDAQ Still 1000+Pts Under 2000 High Levels After a 10% sell-off in early October many large cap biopharmaceutical and diagnostic stocks are at...
Rayno Life Science Update #2: ALKS, ALXN, IMGN Up on Q3 Reports
Biopharmaceutical stocks were somewhat mixed today yet we have some nice moves in our portfolio: Alexion (ALXN $125.26) up 7.34% on Q3 Results which showed a 36% increase in sales to $400M and Net...
Rayno Life Science Update: CPHD,CSII,ILMN are Big Movers
Biotech Stocks Have Recovered From Early October Lows We have been traveling for two weeks and have not posted new content nor made portfolio changes. Despite a significant correction in the biotech...
Travel Notice//Update 2 10/21
Expect to be back by 10/25 in the meantime see previous two posts. Biotech stocks remain choppy. Hold mode with 10% cash. Big action has moved to Internets and new media. See Raynoreport.com...
Valuation Models for Biopharmaceutical Stocks
Are Biotech Valuations in the "Bubblet" Phase? In September of 2013 we wrote about the valuations of biotechnology companies from an M&A perspective after the acquisition of Onyx Pharmaceuticals...
Risk is Rising-Caution in Biopharmaceutical Stocks
Our Indicators Flash a Caution Signal Today No Change in Portfolio Picks If you are not at 10% cash in your biotechnology portfolio it is time to take profits or hedge your portfolio. If your...
Market Sell-Off Accelerating As Shut-Down Drags On Update 10/4 CLDX
Life Science Trading Update 10/4/13 NASDAQ up 0.88% at 3809 Is the market expecting Boehner to settle? Green screen today with most market leaders up about 2%: AMGN, BIIB, PCYC, REGN, VPHM....